LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1.7783
 45.25 84.90 77 4539 0.0170 -0.0169
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 45.25 84.90 1501 4539 0.3306 0.6493
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 45.25 84.90 269 4539 0.0593 0.2225
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 45.25 84.90 1856 4539 0.4088 0.7114
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 46.95 84.90 95 4952 0.0192 0.0194
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 46.95 84.90 1559 4952 0.3148 0.6423
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 46.95 84.90 286 4952 0.0577 0.2300
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 46.95 84.90 1916 4952 0.3869 0.7011
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 48.65 84.90 101 5328 0.0190 0.0295
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 48.65 84.90 1636 5328 0.3070 0.6412
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 48.65 84.90 297 5328 0.0557 0.2333
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 48.65 84.90 2035 5328 0.3819 0.7023
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 50.36 84.90 128 5651 0.0227 0.0701
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 50.36 84.90 1717 5651 0.3038 0.6429
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 50.36 84.90 294 5651 0.0520 0.2276
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 50.36 84.90 2062 5651 0.3649 0.6933
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 52.06 84.90 136 5990 0.0227 0.0798
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 52.06 84.90 1796 5990 0.2998 0.6437
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 52.06 84.90 318 5990 0.0531 0.2399
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 52.06 84.90 2145 5990 0.3581 0.6920
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 53.77 84.90 142 6252 0.0227 0.0865
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 53.77 84.90 1858 6252 0.2972 0.6446
MN20160318_Q02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 53.77 84.90 344 6252 0.0550 0.2531
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 53.77 84.90 2261 6252 0.3616 0.6975
MN20160318_Q02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 55.48 84.90 122 6567 0.0186 0.0595
MN20160318_Q02
F13